Item 5.03 Amendments to Articles of Incorporation or Bylaws: Change in Fiscal Year.

Name Change

On December 27, 2018, Harrow Health, Inc. (formerly, Imprimis Pharmaceuticals, Inc.) (the "Company") amended its restated certificate of incorporation ("Amendment") to change its corporate name from "Imprimis Pharmaceuticals, Inc." to "Harrow Health, Inc."

The name change was previously approved by the Board of Directors. The shareholders, under Delaware General Corporation Law, were not required to approve the name change.

The stockholders do not need to take any action as a result of the name change, including that there is no need to exchange their certificates representing their shares of common stock. The current stock certificate will continue to represent their ownership interest in the Company. Stockholders, however, may return their certificates to the transfer agent for the Company and obtain an updated certificate.

A copy of the Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K.

The press release relating to the name change being completed and reflected on The NASDAQ Capital Market is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 8.01 Other Events



Symbol Change

The trading symbol reflecting the new name for the company, for the common stock of the Company, on The NASDAQ Capital Market is HROW.

Item 9.01. Financial Statements and Exhibits

(d)    Exhibits

Item   Description

3.1      Amendment to the Restated Certificate of Incorporation for the name
       change, filed as of December 27, 2018

99.1     Press Release issued by Harrow Health, Inc. on December 31, 2018

© Edgar Online, source Glimpses